Toolkit/fluorescence method

fluorescence method

Assay Method·Research·Since 2023

Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

The fluorescence method is a signal transformation modality used in CRISPR-Cas pathogen nucleic acid diagnostic platforms. In the cited context, Cas effector proteins recognize and cleave specific DNA or RNA targets, and fluorescence is combined with signal amplification and transformation technologies to report detection.

Usefulness & Problems

Why this is useful

This method is useful as a readout strategy for CRISPR-Cas-based molecular diagnosis of pathogen nucleic acids. The available evidence indicates that fluorescence serves as part of signal transformation workflows coupled to Cas-mediated target recognition and cleavage.

Source:

Researchers have developed many diagnostic platforms with high sensitivity, high specificity, and low cost by using Cas proteins (Cas9, Cas12, Cas13, Cas14, etc.) in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)

Problem solved

It helps convert Cas protein activity on specific pathogen-derived DNA or RNA sequences into a detectable diagnostic signal. The cited literature specifically places fluorescence within platforms designed for rapid pathogen nucleic acid detection.

Source:

Researchers have developed many diagnostic platforms with high sensitivity, high specificity, and low cost by using Cas proteins (Cas9, Cas12, Cas13, Cas14, etc.) in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)

Problem links

Need a controllable or interpretable biological readout

Derived

The fluorescence method is described as a signal transformation modality used in CRISPR-Cas-based pathogen nucleic acid diagnostic platforms. In this context, Cas proteins recognize and cleave specific DNA or RNA targets, and fluorescence is used in combination with signal amplification and transformation technologies for detection.

Taxonomy & Function

Primary hierarchy

Technique Branch

Method: A concrete measurement method used to characterize an engineered system.

Target processes

diagnostic

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: sensor

The available evidence indicates implementation within CRISPR-Cas diagnostic systems that include Cas proteins plus signal amplification and signal transformation components. No specific construct architecture, reporter molecule, reaction conditions, cofactor requirements, or instrumentation details are provided in the supplied sources.

The supplied evidence does not specify which fluorescent chemistries, reporter designs, Cas proteins, wavelengths, limits of detection, or pathogen panels were validated for this fluorescence method. Independent replication and comparative performance against other readout modalities are not established from the provided material.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1application summarysupports2023Source 1needs review

Researchers have developed diagnostic platforms for pathogen nucleic acid detection using Cas proteins together with signal amplification and signal transformation technologies.

Researchers have developed many diagnostic platforms with high sensitivity, high specificity, and low cost by using Cas proteins (Cas9, Cas12, Cas13, Cas14, etc.) in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)
Claim 2application summarysupports2023Source 1needs review

Researchers have developed diagnostic platforms for pathogen nucleic acid detection using Cas proteins together with signal amplification and signal transformation technologies.

Researchers have developed many diagnostic platforms with high sensitivity, high specificity, and low cost by using Cas proteins (Cas9, Cas12, Cas13, Cas14, etc.) in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)
Claim 3application summarysupports2023Source 1needs review

Researchers have developed diagnostic platforms for pathogen nucleic acid detection using Cas proteins together with signal amplification and signal transformation technologies.

Researchers have developed many diagnostic platforms with high sensitivity, high specificity, and low cost by using Cas proteins (Cas9, Cas12, Cas13, Cas14, etc.) in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)
Claim 4application summarysupports2023Source 1needs review

Researchers have developed diagnostic platforms for pathogen nucleic acid detection using Cas proteins together with signal amplification and signal transformation technologies.

Researchers have developed many diagnostic platforms with high sensitivity, high specificity, and low cost by using Cas proteins (Cas9, Cas12, Cas13, Cas14, etc.) in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)
Claim 5application summarysupports2023Source 1needs review

Researchers have developed diagnostic platforms for pathogen nucleic acid detection using Cas proteins together with signal amplification and signal transformation technologies.

Researchers have developed many diagnostic platforms with high sensitivity, high specificity, and low cost by using Cas proteins (Cas9, Cas12, Cas13, Cas14, etc.) in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)
Claim 6application summarysupports2023Source 1needs review

Researchers have developed diagnostic platforms for pathogen nucleic acid detection using Cas proteins together with signal amplification and signal transformation technologies.

Researchers have developed many diagnostic platforms with high sensitivity, high specificity, and low cost by using Cas proteins (Cas9, Cas12, Cas13, Cas14, etc.) in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)
Claim 7application summarysupports2023Source 1needs review

Researchers have developed diagnostic platforms for pathogen nucleic acid detection using Cas proteins together with signal amplification and signal transformation technologies.

Researchers have developed many diagnostic platforms with high sensitivity, high specificity, and low cost by using Cas proteins (Cas9, Cas12, Cas13, Cas14, etc.) in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)
Claim 8application summarysupports2023Source 1needs review

Researchers have developed diagnostic platforms for pathogen nucleic acid detection using Cas proteins together with signal amplification and signal transformation technologies.

Researchers have developed many diagnostic platforms with high sensitivity, high specificity, and low cost by using Cas proteins (Cas9, Cas12, Cas13, Cas14, etc.) in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)
Claim 9application summarysupports2023Source 1needs review

Researchers have developed diagnostic platforms for pathogen nucleic acid detection using Cas proteins together with signal amplification and signal transformation technologies.

Researchers have developed many diagnostic platforms with high sensitivity, high specificity, and low cost by using Cas proteins (Cas9, Cas12, Cas13, Cas14, etc.) in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)
Claim 10application summarysupports2023Source 1needs review

Researchers have developed diagnostic platforms for pathogen nucleic acid detection using Cas proteins together with signal amplification and signal transformation technologies.

Researchers have developed many diagnostic platforms with high sensitivity, high specificity, and low cost by using Cas proteins (Cas9, Cas12, Cas13, Cas14, etc.) in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)
Claim 11application summarysupports2023Source 1needs review

Researchers have developed diagnostic platforms for pathogen nucleic acid detection using Cas proteins together with signal amplification and signal transformation technologies.

Researchers have developed many diagnostic platforms with high sensitivity, high specificity, and low cost by using Cas proteins (Cas9, Cas12, Cas13, Cas14, etc.) in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)
Claim 12application summarysupports2023Source 1needs review

Researchers have developed diagnostic platforms for pathogen nucleic acid detection using Cas proteins together with signal amplification and signal transformation technologies.

Researchers have developed many diagnostic platforms with high sensitivity, high specificity, and low cost by using Cas proteins (Cas9, Cas12, Cas13, Cas14, etc.) in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)
Claim 13application summarysupports2023Source 1needs review

Researchers have developed diagnostic platforms for pathogen nucleic acid detection using Cas proteins together with signal amplification and signal transformation technologies.

Researchers have developed many diagnostic platforms with high sensitivity, high specificity, and low cost by using Cas proteins (Cas9, Cas12, Cas13, Cas14, etc.) in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)
Claim 14application summarysupports2023Source 1needs review

Researchers have developed diagnostic platforms for pathogen nucleic acid detection using Cas proteins together with signal amplification and signal transformation technologies.

Researchers have developed many diagnostic platforms with high sensitivity, high specificity, and low cost by using Cas proteins (Cas9, Cas12, Cas13, Cas14, etc.) in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)
Claim 15application summarysupports2023Source 1needs review

Researchers have developed diagnostic platforms for pathogen nucleic acid detection using Cas proteins together with signal amplification and signal transformation technologies.

Researchers have developed many diagnostic platforms with high sensitivity, high specificity, and low cost by using Cas proteins (Cas9, Cas12, Cas13, Cas14, etc.) in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)
Claim 16application summarysupports2023Source 1needs review

Researchers have developed diagnostic platforms for pathogen nucleic acid detection using Cas proteins together with signal amplification and signal transformation technologies.

Researchers have developed many diagnostic platforms with high sensitivity, high specificity, and low cost by using Cas proteins (Cas9, Cas12, Cas13, Cas14, etc.) in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)
Claim 17application summarysupports2023Source 1needs review

Researchers have developed diagnostic platforms for pathogen nucleic acid detection using Cas proteins together with signal amplification and signal transformation technologies.

Researchers have developed many diagnostic platforms with high sensitivity, high specificity, and low cost by using Cas proteins (Cas9, Cas12, Cas13, Cas14, etc.) in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)
Claim 18application summarysupports2023Source 1needs review

Researchers have developed diagnostic platforms for pathogen nucleic acid detection using Cas proteins together with signal amplification and signal transformation technologies.

Researchers have developed many diagnostic platforms with high sensitivity, high specificity, and low cost by using Cas proteins (Cas9, Cas12, Cas13, Cas14, etc.) in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)
Claim 19application summarysupports2023Source 1needs review

Researchers have developed diagnostic platforms for pathogen nucleic acid detection using Cas proteins together with signal amplification and signal transformation technologies.

Researchers have developed many diagnostic platforms with high sensitivity, high specificity, and low cost by using Cas proteins (Cas9, Cas12, Cas13, Cas14, etc.) in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)
Claim 20application summarysupports2023Source 1needs review

Researchers have developed diagnostic platforms for pathogen nucleic acid detection using Cas proteins together with signal amplification and signal transformation technologies.

Researchers have developed many diagnostic platforms with high sensitivity, high specificity, and low cost by using Cas proteins (Cas9, Cas12, Cas13, Cas14, etc.) in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)
Claim 21application summarysupports2023Source 1needs review

Researchers have developed diagnostic platforms for pathogen nucleic acid detection using Cas proteins together with signal amplification and signal transformation technologies.

Researchers have developed many diagnostic platforms with high sensitivity, high specificity, and low cost by using Cas proteins (Cas9, Cas12, Cas13, Cas14, etc.) in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)
Claim 22application summarysupports2023Source 1needs review

Researchers have developed diagnostic platforms for pathogen nucleic acid detection using Cas proteins together with signal amplification and signal transformation technologies.

Researchers have developed many diagnostic platforms with high sensitivity, high specificity, and low cost by using Cas proteins (Cas9, Cas12, Cas13, Cas14, etc.) in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)
Claim 23application summarysupports2023Source 1needs review

Researchers have developed diagnostic platforms for pathogen nucleic acid detection using Cas proteins together with signal amplification and signal transformation technologies.

Researchers have developed many diagnostic platforms with high sensitivity, high specificity, and low cost by using Cas proteins (Cas9, Cas12, Cas13, Cas14, etc.) in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)
Claim 24application summarysupports2023Source 1needs review

Researchers have developed diagnostic platforms for pathogen nucleic acid detection using Cas proteins together with signal amplification and signal transformation technologies.

Researchers have developed many diagnostic platforms with high sensitivity, high specificity, and low cost by using Cas proteins (Cas9, Cas12, Cas13, Cas14, etc.) in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)
Claim 25application summarysupports2023Source 1needs review

Researchers have developed diagnostic platforms for pathogen nucleic acid detection using Cas proteins together with signal amplification and signal transformation technologies.

Researchers have developed many diagnostic platforms with high sensitivity, high specificity, and low cost by using Cas proteins (Cas9, Cas12, Cas13, Cas14, etc.) in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)
Claim 26application summarysupports2023Source 1needs review

Researchers have developed diagnostic platforms for pathogen nucleic acid detection using Cas proteins together with signal amplification and signal transformation technologies.

Researchers have developed many diagnostic platforms with high sensitivity, high specificity, and low cost by using Cas proteins (Cas9, Cas12, Cas13, Cas14, etc.) in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)
Claim 27application summarysupports2023Source 1needs review

Researchers have developed diagnostic platforms for pathogen nucleic acid detection using Cas proteins together with signal amplification and signal transformation technologies.

Researchers have developed many diagnostic platforms with high sensitivity, high specificity, and low cost by using Cas proteins (Cas9, Cas12, Cas13, Cas14, etc.) in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)
Claim 28mechanistic summarysupports2023Source 1needs review

Cas effector proteins recognize and cut specific DNA or RNA sequences, which underlies their use in molecular diagnosis.

Cas effector proteins have endonucleases, and become a hotspot in the field of molecular diagnosis because they recognize and cut specific DNA or RNA sequences.
Claim 29mechanistic summarysupports2023Source 1needs review

Cas effector proteins recognize and cut specific DNA or RNA sequences, which underlies their use in molecular diagnosis.

Cas effector proteins have endonucleases, and become a hotspot in the field of molecular diagnosis because they recognize and cut specific DNA or RNA sequences.
Claim 30mechanistic summarysupports2023Source 1needs review

Cas effector proteins recognize and cut specific DNA or RNA sequences, which underlies their use in molecular diagnosis.

Cas effector proteins have endonucleases, and become a hotspot in the field of molecular diagnosis because they recognize and cut specific DNA or RNA sequences.
Claim 31mechanistic summarysupports2023Source 1needs review

Cas effector proteins recognize and cut specific DNA or RNA sequences, which underlies their use in molecular diagnosis.

Cas effector proteins have endonucleases, and become a hotspot in the field of molecular diagnosis because they recognize and cut specific DNA or RNA sequences.
Claim 32mechanistic summarysupports2023Source 1needs review

Cas effector proteins recognize and cut specific DNA or RNA sequences, which underlies their use in molecular diagnosis.

Cas effector proteins have endonucleases, and become a hotspot in the field of molecular diagnosis because they recognize and cut specific DNA or RNA sequences.
Claim 33mechanistic summarysupports2023Source 1needs review

Cas effector proteins recognize and cut specific DNA or RNA sequences, which underlies their use in molecular diagnosis.

Cas effector proteins have endonucleases, and become a hotspot in the field of molecular diagnosis because they recognize and cut specific DNA or RNA sequences.
Claim 34mechanistic summarysupports2023Source 1needs review

Cas effector proteins recognize and cut specific DNA or RNA sequences, which underlies their use in molecular diagnosis.

Cas effector proteins have endonucleases, and become a hotspot in the field of molecular diagnosis because they recognize and cut specific DNA or RNA sequences.
Claim 35mechanistic summarysupports2023Source 1needs review

Cas effector proteins recognize and cut specific DNA or RNA sequences, which underlies their use in molecular diagnosis.

Cas effector proteins have endonucleases, and become a hotspot in the field of molecular diagnosis because they recognize and cut specific DNA or RNA sequences.
Claim 36mechanistic summarysupports2023Source 1needs review

Cas effector proteins recognize and cut specific DNA or RNA sequences, which underlies their use in molecular diagnosis.

Cas effector proteins have endonucleases, and become a hotspot in the field of molecular diagnosis because they recognize and cut specific DNA or RNA sequences.
Claim 37mechanistic summarysupports2023Source 1needs review

Cas effector proteins recognize and cut specific DNA or RNA sequences, which underlies their use in molecular diagnosis.

Cas effector proteins have endonucleases, and become a hotspot in the field of molecular diagnosis because they recognize and cut specific DNA or RNA sequences.
Claim 38review scope summarysupports2023Source 1needs review

The review summarizes rapid pathogen nucleic acid detection technologies based on the trans-cleavage activity of Cas proteins.

This paper introduces the biological mechanism and classification of CRISPR-Cas technology, summarizes the existing rapid detection technology for pathogen nucleic acid based on the trans cleavage activity of Cas
Claim 39review scope summarysupports2023Source 1needs review

The review summarizes rapid pathogen nucleic acid detection technologies based on the trans-cleavage activity of Cas proteins.

This paper introduces the biological mechanism and classification of CRISPR-Cas technology, summarizes the existing rapid detection technology for pathogen nucleic acid based on the trans cleavage activity of Cas
Claim 40review scope summarysupports2023Source 1needs review

The review summarizes rapid pathogen nucleic acid detection technologies based on the trans-cleavage activity of Cas proteins.

This paper introduces the biological mechanism and classification of CRISPR-Cas technology, summarizes the existing rapid detection technology for pathogen nucleic acid based on the trans cleavage activity of Cas
Claim 41review scope summarysupports2023Source 1needs review

The review summarizes rapid pathogen nucleic acid detection technologies based on the trans-cleavage activity of Cas proteins.

This paper introduces the biological mechanism and classification of CRISPR-Cas technology, summarizes the existing rapid detection technology for pathogen nucleic acid based on the trans cleavage activity of Cas
Claim 42review scope summarysupports2023Source 1needs review

The review summarizes rapid pathogen nucleic acid detection technologies based on the trans-cleavage activity of Cas proteins.

This paper introduces the biological mechanism and classification of CRISPR-Cas technology, summarizes the existing rapid detection technology for pathogen nucleic acid based on the trans cleavage activity of Cas
Claim 43review scope summarysupports2023Source 1needs review

The review summarizes rapid pathogen nucleic acid detection technologies based on the trans-cleavage activity of Cas proteins.

This paper introduces the biological mechanism and classification of CRISPR-Cas technology, summarizes the existing rapid detection technology for pathogen nucleic acid based on the trans cleavage activity of Cas
Claim 44review scope summarysupports2023Source 1needs review

The review summarizes rapid pathogen nucleic acid detection technologies based on the trans-cleavage activity of Cas proteins.

This paper introduces the biological mechanism and classification of CRISPR-Cas technology, summarizes the existing rapid detection technology for pathogen nucleic acid based on the trans cleavage activity of Cas
Claim 45review scope summarysupports2023Source 1needs review

The review summarizes rapid pathogen nucleic acid detection technologies based on the trans-cleavage activity of Cas proteins.

This paper introduces the biological mechanism and classification of CRISPR-Cas technology, summarizes the existing rapid detection technology for pathogen nucleic acid based on the trans cleavage activity of Cas
Claim 46review scope summarysupports2023Source 1needs review

The review summarizes rapid pathogen nucleic acid detection technologies based on the trans-cleavage activity of Cas proteins.

This paper introduces the biological mechanism and classification of CRISPR-Cas technology, summarizes the existing rapid detection technology for pathogen nucleic acid based on the trans cleavage activity of Cas
Claim 47review scope summarysupports2023Source 1needs review

The review summarizes rapid pathogen nucleic acid detection technologies based on the trans-cleavage activity of Cas proteins.

This paper introduces the biological mechanism and classification of CRISPR-Cas technology, summarizes the existing rapid detection technology for pathogen nucleic acid based on the trans cleavage activity of Cas

Approval Evidence

1 source1 linked approval claimfirst-pass slug fluorescence-method
in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)

Source:

application summarysupports

Researchers have developed diagnostic platforms for pathogen nucleic acid detection using Cas proteins together with signal amplification and signal transformation technologies.

Researchers have developed many diagnostic platforms with high sensitivity, high specificity, and low cost by using Cas proteins (Cas9, Cas12, Cas13, Cas14, etc.) in combination with signal amplification and transformation technologies (fluorescence method, lateral flow technology, etc.)

Source:

Comparisons

Source-backed strengths

The method is supported as part of CRISPR-Cas diagnostic platforms that leverage the intrinsic sequence specificity of Cas effectors for DNA or RNA recognition and cleavage. It is also explicitly described as compatible with signal amplification and signal transformation technologies in pathogen detection workflows.

Compared with CRISPR-Cas technology

fluorescence method and CRISPR-Cas technology address a similar problem space because they share diagnostic.

Shared frame: shared target processes: diagnostic; shared mechanisms: sequence-specific nucleic acid recognition, trans-cleavage

fluorescence method and lateral flow technology address a similar problem space because they share diagnostic.

Shared frame: same top-level item type; shared target processes: diagnostic

Compared with OptoAssay

fluorescence method and OptoAssay address a similar problem space because they share diagnostic.

Shared frame: same top-level item type; shared target processes: diagnostic

Relative tradeoffs: appears more independently replicated.

Ranked Citations

  1. 1.
    StructuralSource 1Frontiers in Molecular Biosciences2023Claim 26Claim 27Claim 27

    Seeded from load plan for claim cl2. Extracted from this source document.